Gennova Biopharmaceuticals Limited

Develops and produces biotech and pharmaceutical products for chronic diseases.

2001 | Pune, Maharashtra (India) | Active
Last Updated:

Gennova Biopharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 65.00 Cr
  • Paid Up Capital ₹ 5.51 Cr
  • Company Age 23 Year, 9 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 212.90 Cr
  • Satisfied Charges ₹ 133.73 Cr
  • Revenue Growth 9.75%
  • Profit Growth 83.26%
  • Ebitda 42.20%
  • Net Worth 16.50%
  • Total Assets 14.08%

About Gennova Biopharmaceuticals

Gennova Biopharmaceuticals Limited (GBL) is a leading Public Limited Indian Non-Government Company incorporated in India on 19 June 2001 and has a history of 23 years and nine months. Its registered office is in Pune, Maharashtra, India.

The Corporate was formerly known as Emcure Dragon Biotech Limited. The Company is engaged in the Life Sciences Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 65.00 Cr and a paid-up capital of Rs 5.51 Cr.

The company currently has active open charges totaling ₹212.90 Cr. The company has closed loans amounting to ₹133.73 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Gennova Biopharmaceuticals Limited India are Rutuja Gohad as COMPANY SECRETARY and Sanjay Singh as Ceo. Shailesh Ayyangar, Sanjay Singh, Vikas Thapar, and Three other members serve as directors at the Company.

Company Details

  • Location

    Pune, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24231PN2001PLC016253

  • Company No.

    016253

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    19 Jun 2001

  • Date of AGM

    05 Jun 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Pune

Industry

Life Sciences
Company report

Gennova Biopharmaceuticals Limited

Explore comprehensive data for Gennova Biopharmaceuticals Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Gennova Biopharmaceuticals?

Executive Team (2)

NameDesignationAppointment DateStatus
Rutuja Gohad Country flag representing In Company Secretary16-May-2015Current
Sanjay Singh CEO19-Apr-2007Current

Board Members (6)

NameDesignationAppointment DateStatus
Sanjay Singh Country flag representing In Whole-Time Director 19-Apr-2007Current
Shailesh Ayyangar Country flag representing Io Director 26-Jul-2021Current
Vikas Thapar Country flag representing Us Additional Director 07-Nov-2024Current
Kavita Singh Country flag representing In Director 24-Jan-2023Current
Samit Mehta Country flag representing In Whole-Time Director 09-Sep-2011Current
Sunil Mehta Country flag representing In Director 19-Jun-2001Current

Financial Performance of Gennova Biopharmaceuticals.

Gennova Biopharmaceuticals Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.75% increase. The company also saw a substantial improvement in profitability, with a 83.26% increase in profit. The company's net worth Soared by an impressive increase of 16.5%.

Gennova Biopharmaceuticals revenue growth over time
Gennova Biopharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
9.75%
Revenue from Operations
9.63%
Total Assets
14.08%
Profit or Loss
83.26%
Net Worth
16.50%
EBITDA
42.20%

What is the Ownership and Shareholding Structure of Gennova Biopharmaceuticals?

In 2023, Gennova Biopharmaceuticals had a promoter holding of 87.95% and a public holding of 12.05%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹212.90 Cr

Satisfied Charges

₹133.73 Cr

Charges Breakdown by Lending Institutions

  • Others : 107.00 Cr
  • Axis Bank Limited : 55.90 Cr
  • Citi Bank N.A. : 50.00 Cr

Latest Charge Details

DateLenderAmountStatus
30 Oct 2022Citi Bank N.A.₹50.00 CrOpen
20 May 2022Axis Bank Limited₹55.00 CrOpen
02 Sep 2021Others₹107.00 CrOpen
30 Jun 2021Axis Bank Limited₹9.00 MOpen
25 Jun 2021Others₹22.50 CrSatisfied

How Many Employees Work at Gennova Biopharmaceuticals?

Gennova Biopharmaceuticals has a workforce of 705 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Gennova Biopharmaceuticals Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Gennova Biopharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gennova Biopharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Gennova Biopharmaceuticals

Recent activity within the organization

  • Director Appointment

    Vikas Madan Thapar was appointed as a Additional Director was appointed as a Additional Director on 07 Nov 2024 & has been associated with this company since 5 months 6 days .

  • Annual General Meeting

    Gennova Biopharmaceuticals Limited last Annual general meeting of members was held on 05 Jun 2024 as per latest MCA records.

  • Balance Sheet

    Gennova Biopharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune.

  • Charges

    A charge with Others of Rs. 107.00 Cr registered on 02 Sep 2021 with Charge ID 100483894 was modified on 07 Mar 2024.

  • Charges

    A charge registered on 11 Jan 2017 via Charge ID 100126176 with Others was fully satisfied on 28 Feb 2024.

  • Charges

    A charge registered on 30 Jun 2004 via Charge ID 90086867 with The Bank Of Maharashtra Limited was fully satisfied on 28 Feb 2024.

Recent News, Updates & Announcement

Frequently asked questions

  • What is the Incorporation or founding date of Gennova Biopharmaceuticals Limited?

    Gennova Biopharmaceuticals Limited was incorporated on 19 Jun 2001.

  • What is authorized share capital and paid-up capital of Gennova Biopharmaceuticals Limited?

    The authorized share capital of Gennova Biopharmaceuticals Limited is ₹ 65.00 Cr and paid-up capital is ₹ 5.51 Cr.

  • Who are the current board members & directors of Gennova Biopharmaceuticals Limited?

    Currently 8 directors are associated with Gennova Biopharmaceuticals Limited.

    • Shailesh Kripalu Ayyangar
    • Sanjay Singh
    • Vikas Madan Thapar
    • Kavita Singh
    • Rutuja Dilip Gohad
    • Sanjay Singh
    • Samit Satish Mehta
    • Sunil Rajanikant Mehta

  • What is the registered address of Gennova Biopharmaceuticals Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Gennova Biopharmaceuticals Limited is Plot No. P-1 P-2 It-Bt Park Phase - Ii, M.I.D.C. India, Pune City, Maharashtra, 411057.

  • What is the corporate identification number (CIN) and company number of Gennova Biopharmaceuticals Limited?

    The corporate identification number (CIN) of Gennova Biopharmaceuticals Limited is U24231PN2001PLC016253 and the company number is 016253 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Gennova Biopharmaceuticals Limited?

    The Official website of Gennova Biopharmaceuticals Limited is https://www.gennova.bio

  • What has been the recent revenue trend for Gennova Biopharmaceuticals Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Gennova Biopharmaceuticals Limited has risen by 9.75%.

  • How many employees does Gennova Biopharmaceuticals Limited currently have?

    As Per 2023 financial reports, 705 employees are currently employed by Gennova Biopharmaceuticals Limited.

  • What change has been observed in the net worth of Gennova Biopharmaceuticals Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Gennova Biopharmaceuticals Limited has experienced an upsurge of 16.50%.

  • What are the total open charges for Gennova Biopharmaceuticals Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Gennova Biopharmaceuticals Limited amount to ₹ 212.90 Cr.

  • When was the last Balance Sheet of Gennova Biopharmaceuticals Limited filed with the ROC?

    The most recent Balance Sheet for Gennova Biopharmaceuticals Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Biotechnology